| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 1 | 1 | 1 2000 MOLECULAR IMMUNOLOGY 37(17):1015-1024
Biassoni R; Cantoni C; Falco M; Pende D; Millo R; Moretta L; Bottino C; Moretta A
Human natural killer cell activating receptors | 4 | 1
|
| 2 | 1 | 2 2001 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 285(2):235-243
Onda H; Ohkubo S; Shintani Y; Ogi K; Kikuchi K; Tanaka H; Yamamoto K; Tsuji I; Ishibashi Y; Yamada T; Kitada C; Suzuki N; Sawada H; Nishimura O; Fujino M
A novel secreted tumor antigen with a glycosylphosphatidylinositol-anchored structure ubiquitously expressed in human cancers | 5 | 4
|
| 3 | 1 | 3 2001 CURRENT OPINION IN GASTROENTEROLOGY 17(6):568-572
Golby SJC; Spencer J
Role of innate immunity in cancer | 0 | 0
|
| 4 | 1 | 4 2001 CURRENT OPINION IN IMMUNOLOGY 13(4):458-464
Biron CA; Brossay L
NK cells and NKT cells in innate defense against viral infections | 30 | 2
|
| 5 | 1 | 5 2001 CURRENT OPINION IN IMMUNOLOGY 13(4):465-470
McMahon CW; Raulet DH
Expression and function of NK cell receptors in CD8(+) T cells | 25 | 2
|
| 6 | 1 | 6 2001 DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY 25(8-9):651-682
Magor BG; Magor KE
Evolution of effectors and receptors of innate immunity | 6 | 0
|
| 7 | 1 | 7 2001 HUMAN IMMUNOLOGY 62(10):1153-1158
Ghaderi M; Zake LN; Wallin KL; Wiklund F; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
Tumor necrosis factor A and MHC class I chain related gene a (MIC-A) polymorphisms in Swedish patients with cervical cancer | 5 | 2
|
| 8 | 0 | 8 2001 IMMUNITY 14(2):123-133
Cosman D; Mullberg J; Sutherland CL; Chin W; Armitage R; Fanslow W; Kubin M; Chalupny NJ
ULBPs, novel MHC class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor | 132 | 132
|
| 9 | 1 | 9 2001 IMMUNITY 15(1):83-93
Das H; Groh V; Kuijl C; Sugita M; Morita CT; Spies T; Bukowski JF
MICA engagement by human V gamma 2V delta 2 T cells enhances their antigen-dependent effector function | 37 | 13
|
| 10 | 1 | 10 2001 IMMUNITY 15(2):201-211
O'Callaghan CA; Cerwenka A; Willcox BE; Lanier LL; Bjorkman PJ
Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60 | 20 | 0
|
| 11 | 2 | 11 2001 IMMUNITY 15(3):363-374
Trowsdale J
Genetic and functional relationships between MHC and NK receptor genes | 25 | 3
|
| 12 | 2 | 12 2001 IMMUNITY 15(6):1039-1049
Radaev S; Rostro B; Brooks AG; Colonna M; Sun PD
Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3 | 19 | 9
|
| 13 | 1 | 13 2001 IMMUNOGENETICS 53(4):279-287
Steinle A; Li PW; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family | 35 | 18
|
| 14 | 1 | 14 2001 IMMUNOGENETICS 53(4):347-350
Wilson MJ; Haude A; Trowsdale J
The mouse Dap10 gene | 1 | 1
|
| 15 | 1 | 15 2001 IMMUNOGENETICS 53(8):643-648
Parra-Cuadrado JF; del Moral MG; Garcia-Pavia P; Setien F; Martinez-Naves E
Characterization of the MHC class I-related MR1 locus in nonhuman primates | 0 | 0
|
| 16 | 1 | 16 2001 IMMUNOLOGICAL REVIEWS 181():66-78
Boyington JC; Brooks AG; Sun PD
Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules | 15 | 2
|
| 17 | 1 | 17 2001 IMMUNOLOGICAL REVIEWS 181():170-184
Diefenbach A; Raulet DH
Strategies for target cell recognition by natural killer cells | 20 | 13
|
| 18 | 1 | 18 2001 IMMUNOLOGICAL REVIEWS 181():185-192
Sutherland CL; Chalupny NJ; Cosman D
The UL16-binding proteins, a novel family of MHC class I- related ligands for NKG2D, activate natural killer cell functions | 23 | 15
|
| 19 | 1 | 19 2001 IMMUNOLOGICAL REVIEWS 181():193-202
Lopez-Botet M; Llano M; Ortega M
Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation | 10 | 0
|
| 20 | 1 | 20 2001 IMMUNOLOGICAL REVIEWS 181():203-214
Biassoni R; Cantoni C; Pende D; Sivori S; Parolini S; Vitale M; Bottino C; Moretta A
Human natural killer cell receptors and co-receptors | 21 | 9
|
| 21 | 1 | 21 2001 JOURNAL OF IMMUNOLOGY 167(10):5527-5530
Roberts AI; Lee L; Schwarz E; Groh V; Spies T; Ebert EC; Jabri B
Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment | 14 | 9
|
| 22 | 1 | 22 2001 M S-MEDECINE SCIENCES 17(4):504-509
Schleinitz N; Lopez F; Vivier E; Vely F
Natural killer cells: to kill or not to kill | 2 | 0
|
| 23 | 1 | 23 2001 NATURE 413(6852):165-171
Diefenbach A; Jensen ER; Jamieson AM; Raulet DH
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity | 61 | 31
|
| 24 | 1 | 24 2001 NATURE IMMUNOLOGY 2(4):293-299
Smyth MJ; Godfrey DI; Trapani JA
A fresh look at tumor immunosurveillance and immunotherapy | 56 | 8
|
| 25 | 4 | 25 2001 NATURE MEDICINE 7(11):1178-1180
Lanier LL
A renaissance for the tumor immunosurveillance hypothesis | 8 | 4
|
| 26 | 3 | 26 2001 NATURE REVIEWS IMMUNOLOGY 1(1):41-49
Cerwenka A; Lanier LL
Natural killer cells, viruses and cancer | 43 | 12
|
| 27 | 2 | 27 2001 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 98(20):11521-11526
Cerwenka A; Baron JL; Lanier LL
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo | 42 | 25
|
| 28 | 1 | 28 2001 SCIENCE 294(5542):605-609
Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
Regulation of cutaneous malignancy by gamma delta T cells | 57 | 23
|
| 29 | 1 | 29 2001 TISSUE ANTIGENS 58(6):419-421
Elsner HA; Schroeder M; Blasczyk R
The nucleotide diversity of MICA and MICB suggests the effect of overdominant selection | 0 | 0
|
| 30 | 1 | 30 2001 TRANSFUSION MEDICINE REVIEWS 15(4):255-267
Bessler M; Schaefer A; Keller P
Paroxysmal nocturnal hemoglobinuria: Insights from recent advances in molecular biology | 2 | 0
|
| 31 | 1 | 31 2001 TRENDS IN IMMUNOLOGY 22(7):378-385
Stephens HAF
MICA and MICB genes: can the enigma of their polymorphism be resolved? | 15 | 7
|
| 32 | 1 | 32 2001 TRENDS IN IMMUNOLOGY 22(11):633-640
Cooper MA; Fehniger TA; Caligiuri MA
The biology of human natural killer-cell subsets | 42 | 7
|
| 33 | 2 | 33 2002 ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY 58():1099-1103
Sun PD; Radaev S
Generating isomorphous heavy-atom derivatives by a quick-soak method. Part II: phasing of new structures | 2 | 0
|
| 34 | 1 | 34 2002 ANNUAL REVIEW OF IMMUNOLOGY 20():217-251
Vilches C; Parham P
KIR: Diverse, rapidly evolving receptors of innate and adaptive immunity | 32 | 4
|
| 35 | 2 | 35 2002 ANNUAL REVIEW OF IMMUNOLOGY 20():853-885
Natarajan K; Dimasi N; Wang J; Mariuzza RA; Margulies DH
Structure and function of natural killer cell receptors: Multiple molecular solutions to self, nonself discrimination | 14 | 2
|
| 36 | 1 | 36 2002 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 290(2):722-729
Yamaguchi H; Hashimoto K
Association of MR1 protein, an MHC class I-related molecule, with beta(2)-microglobulin | 3 | 1
|
| 37 | 1 | 37 2002 BLOOD 99(10):3661-3667
Costello RT; Sivori S; Marcenaro E; Lafage-Pochitaloff M; Mozziconacci MJ; Reviron D; Gastaut JA; Pende D; Olive D; Moretta A
Defective expression and function of natural killer cell- triggering receptors in patients with acute myeloid leukemia | 7 | 4
|
| 38 | 2 | 38 2002 BLOOD 100(3):1031-1037
Nagakura S; Ishihara S; Dunn DE; Nishimura J; Kawaguchi T; Horikawa K; Hidaka M; Kagimoto T; Eto N; Mitsuya H; Kinoshita T; Young NS; Nakakuma H
Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro | 3 | 1
|
| 39 | 4 | 39 2002 BLOOD 100(6):1935-1947
Farag SS; Fehniger TA; Ruggeri L; Velardi A; Caligiuri MA
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect | 5 | 1
|
| 40 | 6 | 40 2002 CANCER RESEARCH 62(21):6178-6186
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Major histocompatibility complex class I-related chain a and UL16-binding protein expression on tumor cell lines of different histotypes: Analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity | 4 | 2
|
| 41 | 2 | 41 2002 CELLULAR IMMUNOLOGY 215(1):32-44
Rothenfusser S; Buchwald A; Kock S; Ferrone S; Fisch P
Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gamma delta T lymphocytes | 0 | 0
|
| 42 | 1 | 42 2002 CLINICAL CANCER RESEARCH 8(9):2812-2819
Farag SS; George SL; Lee EJ; Baer M; Dodge RK; Becknell B; Fehniger T; Silverman LR; Crawford J; Bloomfield CD; Larson RA; Schiffer CA; Caligiuri MA
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B Study 9420 | 2 | 1
|
| 43 | 16 | 43 2002 CURRENT OPINION IN IMMUNOLOGY 14(3):306-311
Vivier E; Tomasello E; Paul P
Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? | 11 | 5
|
| 44 | 4 | 44 2002 CURRENT OPINION IN IMMUNOLOGY 14(4):509-516
Moser JM; Byers AM; Lukacher AE
NK cell receptors in antiviral immunity | 5 | 1
|
| 45 | 8 | 45 2002 CURRENT OPINION IN IMMUNOLOGY 14(5):615-621
McQueen KL; Parham P
Variable receptors controlling activation and inhibition of NK cells | 2 | 0
|
| 46 | 1 | 46 2002 EUROPEAN JOURNAL OF IMMUNOLOGY 32(3):597-605
Carayannopoulos LN; Naidenko OV; Kinder J; Ho EL; Fremont DH; Yokoyama WM
Ligands for murine NKG2D display heterogeneous binding behavior | 12 | 9
|
| 47 | 2 | 47 2002 FASEB JOURNAL 16(2):202-206
Ojcius DM; Delarbre C; Kourilsky P; Gachelin G
MHC and MHC-related proteins as pleiotropic signal molecules | 2 | 0
|
| 48 | 3 | 48 2002 GENES AND IMMUNITY 3(5):250-262
Webb JR; Lee SH; Vidal SM
Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match | 4 | 0
|
| 49 | 1 | 49 2002 GENOMICS 79(1):114-123
Radosavljevic M; Cuillerier B; Wilson MJ; Clement O; Wicker S; Gilfillan S; Beck S; Trowsdale J; Bahram S
A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3 | 13 | 9
|
| 50 | 3 | 50 2002 HUMAN IMMUNOLOGY 63(1):8-19
Falk CS; Schendel DJ
Allogeneic MHC class I ligands and their role in positive and negative regulation of human cytotoxic effector cells | 2 | 0
|
| 51 | 4 | 51 2002 HUMAN IMMUNOLOGY 63(9):783-794
Collins RWM; Stephens HAF; Clare MA; Vaughan RW
High resolution molecular phototyping of MICA and MICB alleles using sequence specific primers | 2 | 0
|
| 52 | 3 | 52 2002 IMMUNITY 16(1):77-86
Li PW; McDermott G; Strong RK
Crystal structures of RAE-1 beta and its complex with the activating immunoreceptor NKG2D | 12 | 7
|
| 53 | 5 | 53 2002 IMMUNITY 17(1):19-29
Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
The role of the NKG2D immunoreceptor in immune cell activation and natural killing | 19 | 11
|
| 54 | 2 | 54 2002 IMMUNITY 17(4):487-499
Jabri B; Selby JM; Negulescu H; Lee L; Roberts AI; Beavis A; Lopez-Botet M; Ebert EC; Winchester RJ
TCR specificity dictates CD94/NKG2A expression by human CTL | 4 | 0
|
| 55 | 2 | 55 2002 IMMUNOGENETICS 53(10-11):975-979
Kulski JK; Dunn DS; Hui J; Martinez P; Romphruk AV; Leelayuwat C; Tay GK; Inoko AOH
Alu polymorphism within the MICB gene and association with HLA- B alleles | 3 | 0
|
| 56 | 3 | 56 2002 IMMUNOGENETICS 54(8):527-542
Vossen MTM; Westerhout EM; Soderberg-Naucler C; Wiertz EJHJ
Viral immune evasion: a masterpiece of evolution | 2 | 0
|
| 57 | 13 | 57 2002 IMMUNOLOGICAL REVIEWS 188():9-21
Diefenbach A; Raulet DH
The innate immune response to tumors and its role in the induction of T-cell immunity | 3 | 0
|
| 58 | 2 | 58 2002 IMMUNOLOGICAL REVIEWS 189():179-192
McCann FE; Suhling K; Carlin LM; Eleme K; Taner SB; Yanagi K; Vanherberghen B; French PMW; Davis DM
Imaging immune surveillance by T cells and NK cells | 1 | 0
|
| 59 | 4 | 59 2002 INTERNATIONAL JOURNAL OF CANCER 100(1):63-70
Menier C; Riteau A; Carosella ED; Rouas-Freiss N
MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal | 2 | 0
|
| 60 | 2 | 60 2002 INTERNATIONAL JOURNAL OF HEMATOLOGY 75(2):117-122
Kinoshita T; Inoue N
Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria | 2 | 0
|
| 61 | 1 | 61 2002 JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 49(2):243-253
Griffiths PD
The 2001 Garrod Lecture - The treatment of cytomegalovirus infection | 5 | 0
|
| 62 | 1 | 62 2002 JOURNAL OF CLINICAL INVESTIGATION 110(7):943-953
Markel G; Wolf D; Hanna J; Gazit R; Goldman-Wohl D; Lavy Y; Yagel S; Mandelboim O
Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions | 0 | 0
|
| 63 | 7 | 63 2002 JOURNAL OF EXPERIMENTAL MEDICINE 196(11):1399-1402
Long EO; Rajagopalan S
Stress signals activate natural killer cells | 1 | 1
|
| 64 | 2 | 64 2002 JOURNAL OF EXPERIMENTAL MEDICINE 196(11):1403-1414
Michaelsson J; de Matos CT; Achour A; Lanier LL; Karre K; Soderstrom K
A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition | 2 | 1
|
| 65 | 1 | 65 2002 JOURNAL OF IMMUNOLOGY 168(1):240-252
Shum BP; Flodin LR; Muir DG; Rajalingam R; Khakoo SI; Cleland S; Guethlein LA; Uhrberg M; Parham P
Conservation and variation in human and common chimpanzee CD94 and NKG2 genes | 8 | 5
|
| 66 | 4 | 66 2002 JOURNAL OF IMMUNOLOGY 168(2):671-679
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Cosman D
UL16-Binding proteins, novel MHC class I-Related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells | 17 | 14
|
| 67 | 4 | 67 2002 JOURNAL OF IMMUNOLOGY 168(7):3131-3134
Cerwenka A; O'Callaghan CA; Hamerman JA; Yadav R; Ajayi W; Roopenian DC; Joyce S; Lanier LL
Cutting edge: The minor histocompatibility antigen H60 peptide interacts with both H-2K(b) and NKG2D | 5 | 1
|
| 68 | 2 | 68 2002 JOURNAL OF IMMUNOLOGY 168(7):3155-3164
Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
Syk regulation of phosphoinositide 3-kinase-dependent NK cell function | 5 | 0
|
| 69 | 5 | 69 2002 JOURNAL OF IMMUNOLOGY 169(6):3257-3266
Falk CS; Mach M; Schendel DJ; Weiss EH; Hilgert I; Hahn G
NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation | 1 | 1
|
| 70 | 3 | 70 2002 JOURNAL OF IMMUNOLOGY 169(7):3667-3675
Ho EL; Carayannopoulos LN; Poursine-Laurent J; Kinder J; Plougastel B; Smith HRC; Yokoyama WM
Costimulation of multiple NK cell activation receptors by NKG2D | 5 | 4
|
| 71 | 8 | 71 2002 JOURNAL OF IMMUNOLOGY 169(8):4079-4083
Carayannopoulos LN; Naidenko OV; Fremont DH; Yokoyama WM
Cutting edge: Murine UL16-binding protein-like transcript 1: A newly described transcript encoding a high-affinity ligand for marine NKG2D | 12 | 10
|
| 72 | 6 | 72 2002 JOURNAL OF IMMUNOLOGY 169(8):4098-4102
Salih HR; Rammensee HG; Steinle A
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding | 5 | 4
|
| 73 | 1 | 73 2002 JOURNAL OF IMMUNOLOGY 169(8):4222-4229
Shen XF; Wong SBJ; Buck CB; Zhang JW; Siliciano RF
Direct priming and cross-priming contribute differentially to the induction of CD8(+) CTL following exposure to vaccinia virus via different routes | 1 | 0
|
| 74 | 10 | 74 2002 JOURNAL OF IMMUNOLOGY 169(10):5377-5381
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
Cutting edge: Tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin | 4 | 3
|
| 75 | 4 | 75 2002 JOURNAL OF IMMUNOLOGY 169(11):6279-6285
Radaev S; Kattah M; Zou ZC; Colonna M; Sun PD
Making sense of the diverse ligand recognition by NKG2D | 1 | 0
|
| 76 | 2 | 76 2002 JOURNAL OF LEUKOCYTE BIOLOGY 71(2):173-183
Robertson MJ
Role of chemokines in the biology of natural killer cells | 7 | 1
|
| 77 | 1 | 77 2002 JOURNAL OF VIROLOGY 76(11):5748-5758
Huber MT; Tomazin R; Wisner T; Boname J; Johnson DC
Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread | 4 | 1
|
| 78 | 1 | 78 2002 JOURNAL OF VIROLOGY 76(21):10929-10941
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation | 2 | 0
|
| 79 | 1 | 79 2002 LEUKEMIA 16(5):855-860
Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
A novel mechanism of antitumor response involving the expansion of CD3(+)/CD56(+) large granular lymphocytes triggered by a tumor-expressed activating ligand | 1 | 1
|
| 80 | 5 | 80 2002 LEUKEMIA 16(11):2259-2266
Pascal V; Brunet C; Pradel V; Thirion X; Andre P; Faucher C; Sampol J; Dignat-George F; Blaise D; Vivier E; Chabannon C
Analysis of donor NK and T cells infused in patients undergoing MHC-matched allogeneic hematopoietic transplantation | 0 | 0
|
| 81 | 2 | 81 2002 MICROBES AND INFECTION 4(15):1491-1503
Lee SH; Webb JR; Vidal SM
Innate immunity to cytomegalovirus: the Cmv1 locus and its role in natural killer cell function | 0 | 0
|
| 82 | 3 | 82 2002 MICROBES AND INFECTION 4(15):1505-1512
Arase H; Lanier LL
Virus-driven evolution of natural killer cell receptors | 0 | 0
|
| 83 | 1 | 83 2002 MICROBES AND INFECTION 4(15):1513-1521
Yokoyama WM; Scalzo AA
Natural killer cell activation receptors in innate immunity to infection | 0 | 0
|
| 84 | 6 | 84 2002 MICROBES AND INFECTION 4(15):1523-1530
Robbins SH; Brossay L
NK cell receptors: emerging roles in host defense against infectious agents | 0 | 0
|
| 85 | 8 | 85 2002 MOLECULAR IMMUNOLOGY 38(9):637-660
Borrego F; Kabat J; Kim DK; Lieto L; Maasho K; Pena J; Solana R; Coligan JE
Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells | 8 | 0
|
| 86 | 3 | 86 2002 MOLECULAR IMMUNOLOGY 38(14):1029-1037
Strong RK
Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer | 3 | 1
|
| 87 | 6 | 87 2002 NATURE 419(6908):679-680
Yokoyama WM
Immunology - Catch us if you can | 1 | 1
|
| 88 | 4 | 88 2002 NATURE IMMUNOLOGY 3(6):505-506
Karre K
Clever, cleverer, cleverest | 4 | 2
|
| 89 | 7 | 89 2002 NATURE IMMUNOLOGY 3(6):529-535
Krmpotic A; Busch DH; Bubic I; Gebhardt F; Hengel H; Hasan M; Scalzo AA; Koszinowski UH; Jonjic S
MCMV glycoprotein gp40 confers virus resistance to CD8(+) T cells and NK cells in vivo | 22 | 16
|
| 90 | 5 | 90 2002 NATURE IMMUNOLOGY 3(11):1006-1012
Orange JS; Fassett MS; Koopman LA; Boyson JE; Strominger JL
Viral evasion of natural killer cells | 5 | 1
|
| 91 | 1 | 91 2002 NATURE IMMUNOLOGY 3(11):1019-1025
Yewdell JW; Hill AB
Viral interference with antigen presentation | 3 | 0
|
| 92 | 6 | 92 2002 NATURE IMMUNOLOGY 3(12):1142-1149
Diefenbach A; Tomasello E; Lucas M; Jamieson AM; Hsia JK; Vivier E; Raulet DH
Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D | 15 | 8
|
| 93 | 8 | 93 2002 NATURE IMMUNOLOGY 3(12):1150-1155
Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation | 13 | 6
|
| 94 | 7 | 94 2002 NATURE REVIEWS CANCER 2(11):850-861
Smyth MJ; Hayakawa Y; Takeda K; Yagita H
New aspects of natural-killer-cell surveillance and therapy of cancer | 4 | 0
|
| 95 | 5 | 95 2002 NATURE REVIEWS IMMUNOLOGY 2(12):957-964
Moretta A
Natural killer cells and dendritic cells: Rendezvous in abused tissues | 6 | 0
|
| 96 | 2 | 96 2002 PHYSIOLOGICAL REVIEWS 82(1):97-130
Lipscomb MF; Masten BJ
Dendritic cells: Immune regulators in health and disease | 13 | 0
|
| 97 | 5 | 97 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(5):2584-2586
Spies T
Induction of T cell alertness by bacterial colonization of intestinal epithelium | 2 | 0
|
| 98 | 1 | 98 2002 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 99(11):7570-7575
Wang ECY; McSharry B; Retiere C; Tomasec P; Williams S; Borysiewicz LK; Braud VM; Wilkinson GWG
UL40-mediated NK evasion during productive infection with human cytomegalovirus | 8 | 6
|
| 99 | 1 | 99 2002 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 55(2):149-161
Odeberg J; Cerboni C; Browne H; Karre K; Moller E; Carbone E; Soderberg-Naucler C
Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18 | 0 | 0
|
| 100 | 3 | 100 2002 SCIENCE 296(5566):298-300
Medzhitov R; Janeway CA
Decoding the patterns of self and nonself by the innate immune system | 40 | 2
|
| # | Cited
nodes | Nodes / Authors | GCS | LCS |
| 101 | 1 | 101 2002 SEMINARS IN CANCER BIOLOGY 12(1):57-61
Long EO
Tumor cell recognition by natural killer cells | 4 | 1
|
| 102 | 3 | 102 2002 SPRINGER SEMINARS IN IMMUNOPATHOLOGY 24(2):169-185
Sissons JGP; Carmichael AJ; McKinney N; Sinclair JH; Wills MR
Human cytomegalovirus and immunopathology | 0 | 0
|
| 103 | 3 | 103 2002 TRANSPLANT IMMUNOLOGY 10(2-3):147-164
Middleton D; Curran M; Maxwell L
Natural killer cells and their receptors | 1 | 0
|
| 104 | 6 | 104 2002 TRENDS IN MICROBIOLOGY 10(10):470-474
Scalzo AA
Successful control of viruses by NK cells - a balance of opposing forces? | 2 | 0
|
| 105 | 2 | 105 2002 VIRAL PROTEINS COUNTERACTING HOST DEFENSES 269():117-129
Braud VM; Tomasec P; Wilkinson GWG
Viral evasion of natural killer cells during human cytomegalovirus infection | 2 | 1
|
| 106 | 6 | 106 2003 ANNUAL REVIEW OF IMMUNOLOGY 21():807-839
Pardoll D
Does the immune system see tumors as foreign or self? | 0 | 0
|
| 107 | 12 | 107 2003 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 305(1):129-135
Chalupny NJ; Sutherland CL; Lawrence WA; Rein-Weston A; Cosman D
ULBP4 is a novel ligand for human NKG2D | 0 | 0
|
| 108 | 13 | 108 2003 CURRENT OPINION IN IMMUNOLOGY 15(1):37-44
Diefenbach A; Raulet DH
Innate immune recognition by stimulatory immunoreceptors | 0 | 0
|
| 109 | 7 | 109 2003 CURRENT OPINION IN IMMUNOLOGY 15(1):45-51
French AR; Yokoyama WM
Natural killer cells and viral infections | 0 | 0
|
| 110 | 5 | 110 2003 EUROPEAN JOURNAL OF HAEMATOLOGY 70(5):333-345
Costello RT; Rey J; Fauriat C; Gastaut JA; Olive D
New approaches in the immunotherapy of haematological malignancies | 0 | 0
|
| 111 | 8 | 111 2003 EUROPEAN JOURNAL OF IMMUNOGENETICS 30(3):169-176
Jones DC; Young NT
Natural killer receptor repertoires in transplantation | 0 | 0
|
| 112 | 10 | 112 2003 EUROPEAN JOURNAL OF IMMUNOLOGY 33(1):194-203
Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A
Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein | 1 | 1
|
| 113 | 12 | 113 2003 EUROPEAN JOURNAL OF IMMUNOLOGY 33(2):381-391
Diefenbach A; Hsia JK; Hsiung MYB; Raulet DH
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity | 0 | 0
|
| 114 | 2 | 114 2003 EUROPEAN JOURNAL OF IMMUNOLOGY 33(6):1707-1716
Barel MT; Pizzato N; van Leeuwen D; Le Bouteiller P; Wiertz EJHJ; Lenfant F
Amino acid composition of alpha 1/alpha 2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down- regulation | 0 | 0
|
| 115 | 8 | 115 2003 EXPERT OPINION ON BIOLOGICAL THERAPY 3(2):237-250
Farag SS; Fehniger TA; Becknell B; Blaser BW; Caligiuri MA
New directions in natural killer cell-based immunotherapy of human cancer | 0 | 0
|
| 116 | 9 | 116 2003 IMMUNOGENETICS 55(1):1-9
Radosavljevic M; Bahram S
In vivo immunogenetics: from MIC to RAET1 loci | 0 | 0
|
| 117 | 3 | 117 2003 IMMUNOGENETICS 55(1):16-22
Larson JH; Rebeiz MJ; Stiening CM; Windish RL; Beever JE; Lewin HA
MHC class I-like genes in cattle, MHCLA, with similarity to genes encoding NK cell stimulatory ligands | 0 | 0
|
| 118 | 5 | 118 2003 IMMUNOLOGY AND CELL BIOLOGY 81(2):106-113
Parish CR
Cancer immunotherapy: The past, the present and the future | 0 | 0
|
| 119 | 2 | 119 2003 INTERNATIONAL JOURNAL OF CANCER 104(3):354-361
Jinushi M; Takehara T; Tatsumi T; Kanto T; Groh V; Spies T; Kimura R; Miyagi T; Mochizuki K; Sasaki Y; Hayashi N
Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid | 0 | 0
|
| 120 | 4 | 120 2003 INTERNATIONAL JOURNAL OF HEMATOLOGY 77(2):121-124
Nakakuma H; Kawaguchi T
Pathogenesis of selective expansion of PNH clones | 0 | 0
|
| 121 | 1 | 121 2003 JOURNAL OF BIOLOGICAL CHEMISTRY 278(16):13959-13967
Ohishi K; Nagamune K; Maeda Y; Kinoshita T
Two Subunits of glycosylphosphatidylinositol transamidase, GPI8 and PIG-T, form a functionally important intermolecular disulfide bridge | 0 | 0
|
| 122 | 7 | 122 2003 JOURNAL OF EXPERIMENTAL MEDICINE 197(10):1245-1253
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules | 0 | 0
|
| 123 | 18 | 123 2003 JOURNAL OF EXPERIMENTAL MEDICINE 197(11):1427-1439
Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity | 0 | 0
|
| 124 | 5 | 124 2003 JOURNAL OF IMMUNOLOGY 170(7):3572-3576
Rabinovich BA; Li J; Shannon J; Hurren R; Chalupny J; Cosman D; Miller RG
Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells | 1 | 1
|
| 125 | 1 | 125 2003 JOURNAL OF IMMUNOLOGY 170(8):4196-4200
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein | 1 | 1
|
| 126 | 6 | 126 2003 JOURNAL OF IMMUNOLOGY 170(12):6090-6098
Miley MJ; Truscott SM; Yu YYL; Gilfillan S; Fremont DH; Hansen TH; Lybarger L
Biochemical features of the MHC-related protein 1 consistent with an immunological function | 0 | 0
|
| 127 | 3 | 127 2003 JOURNAL OF VIROLOGY 77(3):1848-1855
Sindhu STAK; Ahmad R; Morisset R; Ahmad A; Menezes J
Peripheral blood cytotoxic gamma delta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4(+) T cells, and their cytocidal potential correlates with viral load | 1 | 0
|
| 128 | 2 | 128 2003 JOURNAL OF VIROLOGY 77(8):4539-4545
Odeberg J; Browne H; Metkar S; Froelich CJ; Branden L; Cosman D; Soderberg-Naucler C
The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins | 0 | 0
|
| 129 | 2 | 129 2003 JOURNAL OF VIROLOGY 77(8):4588-4596
Compton T; Kurt-Jones EA; Boehme KW; Belko J; Latz E; Golenbock DT; Finberg RW
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2 | 0 | 0
|
| 130 | 17 | 130 2003 MICROBES AND INFECTION 5(1):31-37
Watzl C
The NKG2D receptor and its ligands - recognition beyond the "missing self"? | 0 | 0
|
| 131 | 6 | 131 2003 NATURE IMMUNOLOGY 4(6):557-564
Billadeau DD; Upshaw JL; Schoon RA; Dick CJ; Leibson PJ
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk- independent regulatory pathway | 1 | 0
|
| 132 | 8 | 132 2003 NATURE IMMUNOLOGY 4(6):565-572
Zompi S; Hamerman JA; Ogasawara K; Schweighoffer E; Tybulewicz VLJ; Di Santo JP; Lanier LL; Colucci F
NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases | 1 | 0
|
| 133 | 16 | 133 2003 NATURE REVIEWS IMMUNOLOGY 3(4):304-316
Yokoyama WM; Plougastel BFM
Immune functions encoded by the natural killer gene complex | 0 | 0
|